NA
CRMD icon

NewEdge Advisors’s CorMedix CRMD Stock Holding History

NewEdge Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.9K Hold
7,500
– – ﹤0.01% 3085
2026
Q1 		$50.9K Hold
7,500
– – ﹤0.01% 2935
2025
Q4 		$87.2K Hold
7,500
– – ﹤0.01% 2804
2025
Q3 		$87.2K Hold
7,500
– – ﹤0.01% 2645
2025
Q2 		$92.4K Buy
+7,500
New +$82.8K ﹤0.01% 2447
2024
Q1 		– Sell
-500
Closed -$1.88K – 3850
2023
Q4 		$1.88K Buy
+500
New +$1.72K ﹤0.01% 3349

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

NewEdge Advisors's CRMD Position: Q2 2026 in Review

NewEdge Advisors held its CorMedix (CRMD) position steady in Q2 2026 at 7,500 shares worth $58.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3085.

NewEdge Advisors first reported a position in CRMD in Q4 2023 and has held it in 6 quarters since. The position peaked at $92.4K in Q2 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • NewEdge Advisors held 7,500 shares of CorMedix worth $58.9K as of Q2 2026.
  • NewEdge Advisors left its CorMedix share count unchanged in Q2 2026.
  • CorMedix made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #3085 holding.
  • NewEdge Advisors first reported a position in CorMedix in Q4 2023 and has held it in 6 quarters since.
  • NewEdge Advisors's CorMedix position peaked at $92.4K in Q2 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.